Home › Research › Clinical safety
Exercise therapy for the treatment of delirium in the intensive care unit
Luis Garegnani, Diego Ivaldi, Mariana Andrea Burgos, Lucia B Varela, Samanta Díaz Menai, Sabrina Rico, María Lucía Giménez, Camila Micaela Escobar Liquitay et al.. Cochrane Database of Systematic Reviews, 2025-08-12
Topic: Risk, prevention and care in population studies
Plain-language summary
Outcomes of interest were duration of delirium, health-related quality of life, delirium severity, cognitive function, mortality in the ICU, ICU length of stay, hospital length of stay and adverse events. RISK OF BIAS: We used Cochrane's risk of bias 2 tool (RoB 2) for assessing RCTs. SYNTHESIS Exercise therapy compared to no intervention or usual care In adults with a diagnosis of delirium after admission to the ICU, exercise therapy may reduce the duration of delirium (MD -1.07 days, 95% CI -1.75 to -0.39; 4 studies, 121 participants; low-certainty evidence). Additionally, exercise therapy may result in no adverse events in adults with a diagnosis of delirium after admission to the ICU, as no adverse events were reported in either group (2 studies, 90 participants; low-certainty evidence). Exercise therapy probably reduces the ICU length of stay in adults with a diagnosis of delirium after admission to the ICU (MD -2.24 days, 95% CI -3.63 to -0.85; 3 studies, 107 participants; moderate-certainty evidence). None of the included studies assessed health-related quality of life or delirium severity for this comparison. The included studies had an overall high risk of bias, or we had some concerns about the risk of bias, for the different evaluated outcomes. Imprecision in the effect estimates was also a concern due to small sample sizes and limited numbers of events. Exercise therapy compared to pharmacological treatment None of the included studies evaluated a comparison between exercise therapy and pharmacological treatment. AUTHORS' In adults with a diagnosis of delirium after admission to the ICU, exercise therapy may reduce the duration of delirium, probably reduces the ICU length of stay, and may result in no adverse events. None of the included studies reported health-related quality of life or delirium severity, and no studies compared exercise therapy to any pharmacological treatment. The certainty of the evidence was low to moderate. We need further studies assessing the effects of exercise therapy on treating delirium in the ICU. These new studies must address the limitations found in the studies included in this review, especially considering larger sample sizes. Future studies should also focus on health-related quality of life, delirium severity, and cognitive function. They must also compare exercise therapy with additional treatment available in the clinical setting, such as highly disseminated pharmacological treatments, and focus on differe
What this study adds
Evidence grade: High
This is a pooled review of 491 participants. This meta-analysis found low-certainty evidence that exercise therapy may reduce the duration of delirium and moderate-certainty evidence that it probably reduces ICU length of stay in adults with delirium after ICU admission. It is about treating delirium in intensive care, not about treating, curing or preventing Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Garegnani, L., Ivaldi, D., Burgos, M. A., Varela, L. B., Menai, S. D., Rico, S., et al. (2025). Exercise therapy for the treatment of delirium in the intensive care unit. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd015830.pub2
Vancouver
Garegnani L, Ivaldi D, Burgos MA, Varela LB, Menai SD, Rico S, et al. Exercise therapy for the treatment of delirium in the intensive care unit. Cochrane Database of Systematic Reviews. 2025. doi:10.1002/14651858.cd015830.pub2. PMID: 40792601.
BibTeX
@article{garegnani2025-40792601,
author = {Garegnani, Luis and Ivaldi, Diego and Burgos, Mariana Andrea and Varela, Lucia B and Menai, Samanta Díaz and Rico, Sabrina and Giménez, María Lucía and Liquitay, Camila Micaela Escobar and others},
title = {{Exercise therapy for the treatment of delirium in the intensive care unit}},
journal = {Cochrane Database of Systematic Reviews},
year = {2025},
doi = {10.1002/14651858.cd015830.pub2},
pmid = {40792601},
url = {https://doi.org/10.1002/14651858.cd015830.pub2}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Outcomes of interest were duration of delirium, health-related quality of life, delirium severity, cognitive function, mortality in the ICU, ICU length of stay, hospital length of stay and adverse events.
- RISK OF BIAS: We used Cochrane's risk of bias 2 tool (RoB 2) for assessing RCTs.
- SYNTHESIS Exercise therapy compared to no intervention or usual care In adults with a diagnosis of delirium after admission to the ICU, exercise therapy may reduce the duration of delirium (MD -1.07 days, 95% CI -1.75 to -0.39; 4 studies, 121 participants; low-certainty evidence).
- Additionally, exercise therapy may result in no adverse events in adults with a diagnosis of delirium after admission to the ICU, as no adverse events were reported in either group (2 studies, 90 participants; low-certainty evidence).
- Exercise therapy probably reduces the ICU length of stay in adults with a diagnosis of delirium after admission to the ICU (MD -2.24 days, 95% CI -3.63 to -0.85; 3 studies, 107 participants; moderate-certainty evidence).
Why it matters
This meta-analysis found low-certainty evidence that exercise therapy may reduce the duration of delirium and moderate-certainty evidence that it probably reduces ICU length of stay in adults with delirium after ICU admission. It is about treating delirium in intensive care, not about treating, curing or preventing Alzheimer's disease.
Study details
- Study designmeta-analysis
- Participants491
- Evidence strengthHigh
How this study scored 58/100
Published in a leading specialty journal, and it is a meta-analysis pooling many studies. Scored zero for effect reported because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Cochrane Database of Systematic Reviews) |
| Journal's citation record | 3 / 4 | Cochrane Database of Systematic Reviews: journal h-index 468 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 491 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Juan Víctor Ariel Franco: h-index 28 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Heinrich Heine University Düsseldorf: institution h-index 794 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40792601) |
| Free to read | 2 / 2 | Free to read |
| Total | 58 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/14651858.cd015830.pub2
- PubMed: 40792601
- Original source →
- Free full text: PubMed Central →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Clinical safety from nearby years
Also tagged “palliative”
858 studies in the library carry the topic tag “palliative”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 858 tagged studies.